Michael Bent Tignor Form 3 BALCHEM / Michael Bent Tignor ownership change

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0104
Estimated average burden
hours per response:	0.5

1. Name and Address of Reporting Person^*

Tignor Michael Bent

(Last) (First) (Middle)

C/O BALCHEM CORPORATION

52 SUNRISE PARK ROAD

(Street)

NEW HAMPTON NY 10958

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
02/10/2022

3. Issuer Name and Ticker or Trading Symbol
BALCHEM CORP [ BCPC ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
Chief Human Resources Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock(1)	4,654	D
Common Stock(2)	1,790	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	02/21/2018(3)	02/21/2027	Common Stock	8,400	85.4	D
Employee Stock Option (right to buy)	02/15/2019(3)	02/15/2028	Common Stock	2,800	74.57	D
Employee Stock Option (right to buy)	02/13/2020(3)	02/13/2029	Common Stock	3,100	84.09	D
Employee Stock Option (right to buy)	02/13/2021(3)	02/13/2030	Common Stock	2,800	111.94	D
Employee Stock Option (right to buy)	02/11/2022(3)	02/11/2031	Common Stock	2,200	119.13	D
Employee Stock Option (right to buy)	02/10/2023(3)	02/10/2032	Common Stock	2,100	138.07	D

Explanation of Responses:

1. Ownership consists of 886 shares held in Reporting Person's Company 401(k)/profit sharing plan account and 3,768 shares held directly

2. Ownership of restricted stock vests in Reporting Person 3 years following the grant dates and is further subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person.

3. Options vest 20% year 1; 40% year 2; and 40% year 3

	/s/ Michael Brent Tignor, by Attorney in Fact, Travis Larsen	02/17/2022
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.